We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek.

With vast experience in the pharmaceutical industry, he will undoubtedly become a key part of the Quinta team and aid us in our continued growth.

Starting in the industry 30 years ago at the Charles University in Hradec Králové, CZ, he dedicated his career-to-date at Zentiva where he served as a member of the corporate senior management team.

Holding positions of responsibility across Quality, Regulatory, and Pharmacovigilance, he played a key part in the building of a highly renowned quality system and contributed to the Regulatory Affairs function in different stages of Zentiva’s development. Enabling it to grow from a regional player to the global Gx business of Sanofi.

Deeply involved in projects in Europe, Latin America, Southeast Asia & the Middle East throughout his career, he joins QUINTA-ANALYTICA ready to contribute to enhancing our team and ensuring we remain a leading provider of high quality analytical and clinical services for pharmadevelopment and manufacturing.

His experience will further strengthen Quinta and will help power the top-class services we provide globally.

Welcome on-board, Miroslav.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.